Back To Search Instructions
Protocols
37 protocols meet the specified criteria
Disease Site: Other
Protocol No.TitleStatus
0100000331ANBL00B1: Neuroblastoma Biology StudiesOpen
0500000226Arizona Lymphoid Tissue and Blood Repository (ALTBR)Open
1100000212Skin Cancer Institute Patient Registry and Tissue BankOpen
1100000610A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients with Hematologic Malignancies and Other Indications (10-CBA)Open
1200000229Skin Cancer Prevention Program BiorepositoryOpen
1405319847My Life Our Future: A Hemophilia Genotyping Initiative Data and Sample Research RepositoryOpen
1406354010Continuation of a previously approved retrospective review, and a proposal to open a Propsective Registry for patients treated with the Xoft Axxent System device to track safety, efficacy, and cosmetic outcomes in patients with basal and squamous cell cancers.Open
1408448583The Use of In Vivo Confocal Microscopy In Normal and Pathological Cutaneous Lesions Open
1409505107Pilot Study to Evaluate the Signaling Pathway Modulation Demonstrated by Raf, MEK, and Kinase Inhibitors In Human Skin With or Without Solar Simulated LightOpen
1412585986Clinical, Morphological, and Histological Effect of Emollient Application in Actinic KeratosesOpen
1502660379S1316: Prospective Comparative Effectiveness Trial for Malignant Bowel ObstructionOpen
1604498313Preclinical Investigation of Novel Therapeutic Agents for Hematological Malignancies Open
1606616633Phase Ib Trial of Pembrolizumab (MK-3475) in Combination with Dinaciclib (MK-7965) in Subjects with Hematologic Malignancies (KEYNOTE-155)Open
1606636273A Randomized Phase II Trial of Radiation Therapy and Cisplatin Alone or in Combination with Intravenous Triapine in Women with Newly Diagnosed Bulky Stage IB2, Stage II, IIIB, or IVA Cancer of the Uterine Cervix or Stage II-IVA Vaginal CancerOpen
1609876907A Phase I/II Study of Haploidentical Bone Marrow Transplant with Post-Transplant Cyclophosphamide and/or BendamustineOpen
1701157252A Phase III Randomized, Controlled Clinical Trial of Pembrolizumab with or without Platinum-Based Combination Chemotherapy versus Chemotherapy in Subjects with Advanced or Metastatic Urothelial Carcinoma (KEYNOTE 361)Open
1703266800A Phase 1b/2, Open-label, Multicenter, Dose Escalation and Expansion Trial of Intratumoral SD-101 in Combination With Pembrolizumab in Patients With Metastatic Melanoma Open
1704383758A Randomized, Controlled, Phase 3 Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Melphalan/HDS Treatment in Patients with Hepatic-Dominant Ocular MelanomaOpen
1706595817A Multicenter, Two Part Open-Label, Phase 1b Clinical Study of CMP-001 Administered Either in Combination with Pembrolizumab or as Monotherapy in Subjects with Advanced MelanomaOpen
1707620366A Phase 1/2 Study to Assess the Safety and Efficacy of Intratumoral IMO-2125 in Combination with Ipilimumab or Pembrolizumab in Patients with Metastatic MelanomaOpen
1708775881An Open-Label, Phase 1b, Multi-Arm Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of Investigational Treatments in Combination With Standard of Care Immune Checkpoint Inhibitors in Patients With Advanced MelanomaOpen
1709802216Retrospective Review: Targeting hyperactive DNA break repair in glioblastomaOpen
1711022046Clinical Study of Avmacol® for Detoxification of Tobacco Carcinogens in Heavy SmokersOpen
28347FIGHT: A Phase 1/3 Study of FPA144 versus Placebo in Combination with Modified FOLFOX6 in Patients with Previously Untreated Advanced Gastric and Gastroesophageal CancerNot Open
29007NRG HN-004: Randomized Phase II/III Trial of Radiotherapy with Concurrent MEDI4736 (Durvalumab) vs. Radiotherapy with Concurrent Cetuximab in Patients with Stage III-IVB Head and Neck Cancer with a Contraindication to Cisplatin.Not Open
PHX-17-0013-71-16Dosimetric comparison for IMRT, VMAT, SBRT/SRS, & Brachytherapy for extracranial sitesOpen
PHXA-15-0002-10-15Can Diet and Physical Activity Modulate Ovarian Fallopian Tube and Primary Peritoneal Cancer Progression-Free Survival?Open
PHXA-15-0003-10-15GROningen INternational Study on Sentinel nodes in Vulvar cancer GROINSS-V) Closed
PHXA-15-0028-80-15A Phase 3 Placebo-Controlled Study of Carboplatin/Paclitaxel With or Without Concurrent and Continuation Maintenance Veliparib (PARP inhibitor) in Subjects with Previously Untreated Stages III or IV High-Grade Serous Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerClosed
PHXA-17-0030-71-15A retrospective study on the outcome of patients with genitourinary (GU) malignancies who were treated at Dignity Health St. Joseph's Hospital and Medical Center (including University of Arizona Cancer Center at Dignity Health St. Joseph's)Open
PHXB-16-0142-80-15Cyclic PDT for the Prevention of Actinic Keratosis and Non Melanoma Skin Cancer in Solid Organ Transplant RecipientsOpen
PHXE-16-0205-80-15A Phase 2 Study of REGN2810, A fully Human Monoclonal Antibody to Programmed Death - 1 (PD-1), in Patients with Advanced Cutaneous Squamous Cell CarcinomaOpen
PHXE-17-0101-80-15A Phase 2 Study of REGN2810, A Fully Human Monoclonal Antibody to Programmed Death-1, in Patients with Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or were Intolerant of Prior Hedgehog Pathway Inhibitor TherapyOpen
PHXE-17-0117-80-15A Phase 3 Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Determine the Efficacy of Topical SGX301 (Synthetic Hypericin) and Fluorescent Bulb-Light Irradiation for the Treatment of Cutaneous T-Cell LymphomaOpen
PHXE-17-0216-10-15EAY131: Molecular Analysis for Therapy Choice (MATCH) Open
PHXE-17-0349-10-15DART: Dual Anti-CTLA-4 and Anti-PD-1 Blockade in Rare TumorsOpen
TESTCALENDAROpen